Peter Warendorf
Stock Analyst at Barclays
(2.85)
# 2,736
Out of 4,402 analysts
36
Total ratings
76.2%
Success rate
5.1%
Average return
Main Sectors:
Stocks Rated by Peter Warendorf
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Rated: Buy | $110 | $89.02 | +23.57% | 7 | Jun 3, 2026 | |
| PGNY Progyny | Rated: Buy | $23 → $27 | $25.65 | +5.26% | 8 | May 18, 2026 | |
| LFST LifeStance Health Group | Rated: Buy | $9 | $8.61 | +4.53% | 9 | May 12, 2026 | |
| TDOC Teladoc Health | Maintained: Hold | $7 | $7.31 | -4.24% | 7 | May 5, 2026 | |
| TALK Talkspace | Maintained: Hold | $5.5 → $5.25 | $5.21 | +0.77% | 5 | Mar 10, 2026 |
HealthEquity
Jun 3, 2026
Rated: Buy
Price Target: $110
Current: $89.02
Upside: +23.57%
Progyny
May 18, 2026
Rated: Buy
Price Target: $23 → $27
Current: $25.65
Upside: +5.26%
LifeStance Health Group
May 12, 2026
Rated: Buy
Price Target: $9
Current: $8.61
Upside: +4.53%
Teladoc Health
May 5, 2026
Maintained: Hold
Price Target: $7
Current: $7.31
Upside: -4.24%
Talkspace
Mar 10, 2026
Maintained: Hold
Price Target: $5.5 → $5.25
Current: $5.21
Upside: +0.77%